TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22882761

Group type: EXPERIMENTAL
Intervention: de‐Leval's method
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Flam's modification
Number of subjects: 161
Study: 20516676

Group type: EXPERIMENTAL
Intervention: Naftopidil 75 mg once daily (OD) in the evening (group O; n = 41)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Naftopidil 25 mg thrice daily (TID) in the morning, afternoon, and evening (group T; n = 39)
Number of subjects: 80
Study: 18230388

Group type: EXPERIMENTAL
Intervention: He-Ne laser (lambda = 632.8nm, output = 10 mW, energy density = 1.8 J/cm(2)) for 8 days, followed by laser probe treatment at 6 anatomic sites for 5 minutes each.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 24
Study: 15866959

Group type: EXPERIMENTAL
Intervention: Techni-Care (3.0% chloroxylenol)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: DuraPrep (0.7% iodine and 74% isopropyl alcohol)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: ChloraPrep (2% chlorhexidine gluconate and 70% isopropyl alcohol)
Number of subjects: 125
Study: 12030875

Group type: EXPERIMENTAL
Intervention: Avène spring water spray in conjunction with petrolatum ointment
Number of subjects: 74

Group type: COMPARATOR
Intervention: Petrolatum ointment alone
Number of subjects: 74
Study: 10334658

Group type: EXPERIMENTAL
Intervention: 0.83 g plant sterols
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 1.61 g plant sterols
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 3.24 g plant sterols
Number of subjects: 100
Study: 8772751

Group type: EXPERIMENTAL
Intervention: Subintimal resection
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Intimal resection
Number of subjects: 525
Study: 1349666

Group type: EXPERIMENTAL
Intervention: Lumpectomy plus axillary dissection
Number of subjects: 658

Group type: COMPARATOR
Intervention: Lumpectomy alone
Number of subjects: 658
Study: 3971682

Group type: EXPERIMENTAL
Intervention: Patient-controlled intravenous (i.v.) morphine sulfate for 24 hours
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intramuscular (i.m.) morphine sulfate for 24 hours
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Patient-controlled intravenous (i.v.) morphine sulfate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intramuscular (i.m.) morphine sulfate
Number of subjects: 20
Study: 30875381

Group type: EXPERIMENTAL
Intervention: Clinical Decision Support (CDS)
Number of subjects: 3511

Group type: COMPARATOR
Intervention: Control group (no CDS)
Number of subjects: 3511
Study: 29175749

Group type: EXPERIMENTAL
Intervention: Baby-CIMT
Number of subjects: 37

Group type: COMPARATOR
Intervention: Baby-massage
Number of subjects: 37
Study: 27406165

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 86
Study: 24769640

Group type: EXPERIMENTAL
Intervention: Dabrafenib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dacarbazine (DTIC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dabrafenib after crossover from DTIC
Number of subjects: 0
Study: 22522414

Group type: EXPERIMENTAL
Intervention: Mandibular conventional denture or implant overdenture
Number of subjects: 255
Study: 20490465

Group type: EXPERIMENTAL
Intervention: Naltrexone (0, 12, 25, 50, or 100 mg) with active marijuana (3.27% THC)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Naltrexone (0, 12, 25, 50, or 100 mg) with inactive marijuana (0% THC)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Active marijuana (3.27% THC)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Naltrexone alone
Number of subjects: 29
Study: 18581595

Group type: EXPERIMENTAL
Intervention: Supervised moderate‐intensity exercise therapy for 50 min 3 times per week for 5 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Self‐shoulder stretching exercise (Control)
Number of subjects: 40
Study: 16213286

Group type: EXPERIMENTAL
Intervention: Fasting during Ramadan
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (non-fasting)
Number of subjects: 39
Study: 11815427

Group type: EXPERIMENTAL
Intervention: Blockade of ET(A) and ET(B) receptors using BQ-123 (100 nmol/min) and BQ-788 (50 nmol/min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blockade of ET(A/B) receptors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium nitroprusside (SNP) administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: ET-1 receptor antagonism
Number of subjects: 0
Study: 10525694

Group type: EXPERIMENTAL
Intervention: Meniscus arrow
Number of subjects: 68

Group type: COMPARATOR
Intervention: Horizontal suture
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 68
Study: 8742454

Group type: EXPERIMENTAL
Intervention: Minute-scale fluctuations in normalized EEG log spectrum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EEG frequencies during drowsiness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral alertness during drowsiness
Number of subjects: 0
Study: 1523288

Group type: EXPERIMENTAL
Intervention: ritanserin (5 mg orally)
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study: 6337285

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1 g/day of elemental calcium)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 30950743

Group type: EXPERIMENTAL
Intervention: Recline Exercise (RE)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Head Lift Exercise (HLE)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both RE and HLE
Number of subjects: 22
Study: 30547799

Group type: EXPERIMENTAL
Intervention: Educational intervention (Booklet, Continuous Medical Education (CME), and Pamphlet) in group A (n=38)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: OHC pamphlet in group B (n=32)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group C (n=36)
Number of subjects: 106
Study: 27534622

Group type: EXPERIMENTAL
Intervention: Peer-only feedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple stakeholder group feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multiple feedback
Number of subjects: 0
Study: 25095656

Group type: EXPERIMENTAL
Intervention: Alfacalcidol 0.25 microg/day
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Paricalcitol 1 microg/day
Number of subjects: 128

Group type: COMPARATOR
Intervention: No active vitamin D metabolites (control group)
Number of subjects: 128
Study: 22807076

Group type: EXPERIMENTAL
Intervention: DAISY intervention (multifaceted and semi‐tailored counselling, education, and support)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Control support during follow‐up
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: DAISY intervention
Number of subjects: 330
Study: 19614687

Group type: EXPERIMENTAL
Intervention: Carbachol (3 µg/kg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 17039266

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (cyclophosphamide, methotrexate, fluoracil)
Number of subjects: 401

Group type: COMPARATOR
Intervention: Control group (low-risk patients not on chemotherapy)
Number of subjects: 401
Study: 16313543

Group type: EXPERIMENTAL
Intervention: Doubling daily inhaled corticosteroid (ICS) dose (fluticasone)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Maintaining usual ICS dose
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Oral steroids (OS) (dexamethasone)
Number of subjects: 22
Study: 12096825

Group type: EXPERIMENTAL
Intervention: EE/DRSP (30 microg ethinyl estradiol / 3 mg drospirenone)
Number of subjects: 128

Group type: COMPARATOR
Intervention: EE/CPA (35 microg ethinyl estradiol / 2 mg cyproterone acetate)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: EE/DRSP and EE/CPA
Number of subjects: 128
Study: 10616770

Group type: EXPERIMENTAL
Intervention: 30mg LA once daily, 500mg AMPC tid, and 250mg MNZ tid for 2 weeks
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 30mg LA bid, 500mg AMPC tid, and 250mg MNZ tid for 2 weeks
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 30mg LA once daily, 500mg AMPC tid, and 250mg MNZ tid for 1 week
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 30mg LA bid, 500mg AMPC tid, and 250mg MNZ tid for 1 week
Number of subjects: 91
Study: 8847197

Group type: EXPERIMENTAL
Intervention: Home‐like social environment without neuroleptics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual hospital ward treatment with neuroleptic drugs
Number of subjects: 0
Study: 1971166

Group type: EXPERIMENTAL
Intervention: Cocaine administration (2 mg/kg body weight)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intracoronary propranolol administration (2 mg in 5 minutes)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline administration (control)
Number of subjects: 30
Study: 6101847

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31522896

Group type: EXPERIMENTAL
Intervention: Multifaceted, interactive education program
Number of subjects: 177

Group type: COMPARATOR
Intervention: Conventional follow-up
Number of subjects: 177
Study: 31331552

Group type: EXPERIMENTAL
Intervention: 120 twirls per minute on ST9
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 60 twirls per minute on ST9
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 120 twirls per minute on LR3
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 60 twirls per minute on LR3
Number of subjects: 120
Study: 27653670

Group type: EXPERIMENTAL
Intervention: Structured testing group (STG) measuring 7-points on SMBG for 3 consecutive days once every two months
Number of subjects: 62

Group type: COMPARATOR
Intervention: Routine testing group (RTG) measuring SMBG 3 times each week before breakfast on Monday and Friday and before dinner on Wednesday
Number of subjects: 62
Study: 25350366

Group type: EXPERIMENTAL
Intervention: Olanzapine (5 mg/day for 7 days, then 10 mg/day for 7 days)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Olanzapine (in participants who gained weight, n=8)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Olanzapine (in participants who did not gain weight)
Number of subjects: 24
Study: 24332919

Group type: EXPERIMENTAL
Intervention: Mannitol (0.5 g/kg) plus hydration
Number of subjects: 86

Group type: COMPARATOR
Intervention: Hydration alone (controls)
Number of subjects: 86
Study: 22818406

Group type: EXPERIMENTAL
Intervention: Two physical activity consultations and a 10-week group pram-walking program
Number of subjects: 76
Study: 19105621

Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factor and autologous bone marrow-derived stem/progenitor cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17846129

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHP) treatment
Number of subjects: 598
Study: 14691413

Group type: EXPERIMENTAL
Intervention: Percutaneous rotational coronary atherectomy (PRCA)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Balloon angioplasty (PTCA)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: PRCA
Number of subjects: 200

Group type: COMPARATOR
Intervention: PTCA
Number of subjects: 200
Study: 11773913

Group type: EXPERIMENTAL
Intervention: Antithrombotic therapy
Number of subjects: 7081
Study: 9834564

Group type: EXPERIMENTAL
Intervention: Neonates of mothers with pregnancy induced hypertension (PIH)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Neonates born to normotensive mothers
Number of subjects: 30
Study: 7859451

Group type: EXPERIMENTAL
Intervention: TCu 380A IUD
Number of subjects: 0

Group type: COMPARATOR
Intervention: TCu 220C IUD
Number of subjects: 0
Study: 2645490

Group type: EXPERIMENTAL
Intervention: Shepard Teflon grommet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Armstrong beveled tube
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reuter‐Bobbin tube
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Goode T‐tube
Number of subjects: 0
Study: 945688

Group type: EXPERIMENTAL
Intervention: Frozen erythrocytes diluted in plasma
Number of subjects: 43

Group type: COMPARATOR
Intervention: Whole blood less than 5 days old
Number of subjects: 43
Study: 31418804

Group type: EXPERIMENTAL
Intervention: Modified Preauthorization (PA)
Number of subjects: 2692

Group type: EXPERIMENTAL
Intervention: Postprescription Audit and Review (PPR)
Number of subjects: 2692
Study: 28448502

Group type: EXPERIMENTAL
Intervention: Couples counseling training
Number of subjects: 808

Group type: COMPARATOR
Intervention: No couples counseling training (Control)
Number of subjects: 808
Study: 25597438

Group type: EXPERIMENTAL
Intervention: Combination of oxycodone and pregabalin (B1 group)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Combination of oxycodone and pregabalin (B2 group)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Oxycodone (A1 group)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Oxycodone (A2 group)
Number of subjects: 300
Study: 23103352

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZA) and strontium-89 (Sr-89) simultaneously (Group A)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZA) alone (Group B)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Strontium-89 (Sr-89) alone (Group C)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Untreated (Group D)
Number of subjects: 180
Study: 21756432

Group type: EXPERIMENTAL
Intervention: Maltreated Intervention (MI) group (combined child-parent psychotherapy and psychoeducational parenting intervention)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (CS)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Nonmaltreated Comparison (NC) group
Number of subjects: 91
Study: 19936416

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (Group D, n=42)
Number of subjects: 81

Group type: COMPARATOR
Intervention: 0.9% sodium chloride infusion (Group P, n=39)
Number of subjects: 81
Study: 17007855

Group type: EXPERIMENTAL
Intervention: Reverse‐transcription‐polymerase chain reaction (RT‐PCR) analysis of HSPA2 gene expression in adolescents with varicocele and oligozoospermia
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Reverse‐transcription‐polymerase chain reaction (RT‐PCR) analysis of HSPA2 gene expression in adolescents with varicocele and normal sperm concentration
Number of subjects: 2

Group type: COMPARATOR
Intervention: Reverse‐transcription‐polymerase chain reaction (RT‐PCR) analysis of HSPA2 gene expression in adolescents without varicocele (controls)
Number of subjects: 2
Study: 15609737

Group type: EXPERIMENTAL
Intervention: Single-item depression screen
Number of subjects: 1211

Group type: EXPERIMENTAL
Intervention: PHQ-2 score > or =3
Number of subjects: 1211

Group type: COMPARATOR
Intervention: PHQ-9
Number of subjects: 1211

Group type: COMPARATOR
Intervention: PHQ-9 item assessing thoughts of death or suicide
Number of subjects: 1211

Group type: COMPARATOR
Intervention: PHQ-8
Number of subjects: 1211

Group type: EXPERIMENTAL
Intervention: PHQ-2
Number of subjects: 1211
Study: 11286309

Group type: EXPERIMENTAL
Intervention: rt-PA and dalteparin for 4 to 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: rt-PA and UFH for 48 hours
Number of subjects: 0
Study: 9308804

Group type: EXPERIMENTAL
Intervention: Cigarette smoking (measured by follicular fluid concentrations of cotinine)
Number of subjects: 234
Study: 8100289

Group type: EXPERIMENTAL
Intervention: Oxygen
Number of subjects: 14

Group type: COMPARATOR
Intervention: Air
Number of subjects: 14
Study: 3429697

Group type: COMPARATOR
Intervention: 10 mg nifedipine, sublingually administered
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Chronic oral nifedipine, 10 mg qid
Number of subjects: 16
Study: 29679670

Group type: EXPERIMENTAL
Intervention: Mindfulness-based relapse prevention (MBRP) combined with virtual reality cue exposure (VRCE) for 8 weeks
Number of subjects: 180

Group type: COMPARATOR
Intervention: Mindfulness-based relapse prevention (MBRP) alone for 8 weeks
Number of subjects: 180

Group type: COMPARATOR
Intervention: Treatment as usual for 8 weeks
Number of subjects: 180
Study: 27164462

Group type: EXPERIMENTAL
Intervention: Ceftaroline fosamil
Number of subjects: 163

Group type: COMPARATOR
Intervention: Comparator (vancomycin or cefazolin, plus optional aztreonam)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Comparator
Number of subjects: 163
Study: 24553807

Group type: EXPERIMENTAL
Intervention: Video-based intervention (skin self-examination and skin awareness)
Number of subjects: 870

Group type: EXPERIMENTAL
Intervention: Video-based intervention
Number of subjects: 870

Group type: COMPARATOR
Intervention: Control group (brochures only)
Number of subjects: 870
Study: 22545424

Group type: EXPERIMENTAL
Intervention: Oral lornoxicam (8 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral paracetamol (500 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (lornoxicam and paracetamol)
Number of subjects: 60
Study: 19517165

Group type: EXPERIMENTAL
Intervention: Ondansetron (4 mg)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 160
Study: 18450380

Group type: EXPERIMENTAL
Intervention: Epoprostenol (PGI(2)) infusion at 10 ng/kg/min for 25 min
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Epoprostenol (PGI(2)) infusion
Number of subjects: 12
Study: 16835477

Group type: EXPERIMENTAL
Intervention: FOLFIRI regimen (CPT‐11 180 mg/m(2) as a 90‐min infusion on day 1, l‐LV 200 mg/m(2) as a 2‐h infusion during CPT‐11, followed by a bolus dose of 5‐FU 400 mg/m(2) and a 46‐h continuous infusion of 2,400 mg/m(2) every 2 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FOLFIRI regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: oxaliplatin/5‐FU/LV therapy (FOLFOX)
Number of subjects: 0
Study: 15342678

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 65

Group type: COMPARATOR
Intervention: High-MUFA diet
Number of subjects: 65
Study: 11737921

Group type: EXPERIMENTAL
Intervention: Peri-operative pulmonary-artery catheter use
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Activated protein C and low-dose steroids in sepsis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Evidence-based guidelines for the prevention of ventilator-acquired pneumonia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical errors in the critical care unit
Number of subjects: 0
Study: 9148012

Group type: EXPERIMENTAL
Intervention: 1992 study
Number of subjects: 31

Group type: COMPARATOR
Intervention: 1987 study
Number of subjects: 31
Study: 8442393

Group type: EXPERIMENTAL
Intervention: Combination of dipyridamole 75 mg and acetylsalicylic acid 330 mg t.i.d.
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2500
Study: 2945040

Group type: EXPERIMENTAL
Intervention: 42 micrograms HBsAg for each vaccination (Group A)
Number of subjects: 217

Group type: COMPARATOR
Intervention: 84 micrograms for the first and 21 micrograms for the second and third vaccinations (Group B)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Fourth vaccination for non-responders and low-responders (n=40)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Age of participants
Number of subjects: 217
Study: 31347611

Group type: EXPERIMENTAL
Intervention: Gepirone extended-release tablets (gepirone ER, Travivo)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gepirone
Number of subjects: 0
Study: 29974972

Group type: EXPERIMENTAL
Intervention: Alcohol (target breath alcohol level 0.080%)
Number of subjects: 62

Group type: COMPARATOR
Intervention: No alcohol (control group)
Number of subjects: 62
Study: 27795670

Group type: EXPERIMENTAL
Intervention: 10 mg intravenous dexamethasone (DM group)
Number of subjects: 78

Group type: COMPARATOR
Intervention: 0.9% normal saline (NS group)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: DM group
Number of subjects: 78

Group type: COMPARATOR
Intervention: NS group
Number of subjects: 78
Study: 24413969

Group type: EXPERIMENTAL
Intervention: PCIT maintenance treatment (MT)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Assessment‐only follow‐up condition (AO)
Number of subjects: 61
Study: 22791229

Group type: EXPERIMENTAL
Intervention: Cued location (valid cue)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uncued location (invalid cue)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral results with 1,000 ms SOA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N2pc amplitudes across cue types
Number of subjects: 0
Study: 20189653

Group type: EXPERIMENTAL
Intervention: Confocal microscopy (CM) parameters: MGALD, MGASD, ICD, MGAUD
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Confocal microscopy (CM) parameters: MGALD
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Confocal microscopy (CM) parameters: MGASD
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Confocal microscopy (CM) parameters: ICD
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Confocal microscopy (CM) parameters: MGAUD
Number of subjects: 20
Study: 17585021

Group type: EXPERIMENTAL
Intervention: High glucosinolate broccoli
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Standard broccoli
Number of subjects: 16

Group type: COMPARATOR
Intervention: Water
Number of subjects: 16
Study: 15096570

Group type: EXPERIMENTAL
Intervention: Invader biplex assay
Number of subjects: 1448

Group type: COMPARATOR
Intervention: PCR-based methods (AS-PCR, PCR-RFLP, PCR-mass spectrometry)
Number of subjects: 1448
Study: 12043107

Group type: EXPERIMENTAL
Intervention: LCHP ketogenic diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zone diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conventional hypocaloric diabetic exchange diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison across diet groups
Number of subjects: 0
Study: 9829223

Group type: EXPERIMENTAL
Intervention: Thyroid replacement therapy (L-thyroxine) for 3 months
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (46 sex- and age-matched healthy newborns)
Number of subjects: 23
Study: 8160095

Group type: EXPERIMENTAL
Intervention: Percutaneous radiation therapy (12.5 Gy total dose over 5 days with 2.5 Gy per day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Stent implantation alone (no radiation therapy)
Number of subjects: 24